Glycopyrrolate Tablets
» Glycopyrrolate Tablets contain not less than 93.0 percent and not more than 107.0 percent of the labeled amount of glycopyrrolate (C19H28BrNO3).
Packaging and storage— Preserve in tight containers.
Identification— Blend a portion of finely powdered Tablets, equivalent to about 25 mg of glycopyrrolate, with 50 mL of water in a high-speed blender, and pass through very retentive filter paper or other suitable filter, to obtain a clear filtrate: the UV absorption spectrum of the filtrate exhibits maxima and minima at the same wavelengths as that of a solution of USP Glycopyrrolate RS (1 in 2000).
Dissolution, Procedure for a Pooled Sample 711
Medium: water; 500 mL.
Apparatus 1: 100 rpm.
Time: 45 minutes.
Procedure— Determine the amount of C19H28BrNO3 dissolved, employing the procedure set forth in the Assay, making any necessary modifications.
Tolerances— Not less than 75% (Q) of the labeled amount of C19H28BrNO3 is dissolved in 45 minutes.
Uniformity of dosage units 905: meet the requirements.
pH 5.3 Phosphate buffer— Dissolve 38.0 g of monobasic sodium phosphate and 2.0 g of anhydrous dibasic sodium phosphate in sufficient water to make 1000 mL, and adjust, if necessary, to a pH of 5.3 ± 0.1.
Bromocresol purple solution— Dissolve 400 mg of bromocresol purple in 30 mL of alcohol, add 6.3 mL of 0.1 N sodium hydroxide, and dilute with water to 500 mL.
Buffer–dye mixture— On the day of use, mix equal volumes of pH 5.3 Phosphate buffer and of Bromocresol purple solution, and extract with chloroform until the last extract is colorless.
Standard preparation— Transfer about 100 mg of USP Glycopyrrolate RS, accurately weighed, to a 100-mL volumetric flask, add water to volume, and mix. Transfer 10.0 mL of this solution to a second 100-mL volumetric flask, dilute with water to volume, and mix to obtain a Standard preparation having a known concentration of about 100 µg per mL.
Assay preparation— Weigh and finely powder not less than 20 Tablets. Transfer an accurately weighed portion of the powder, equivalent to about 10 mg of glycopyrrolate, to a 100-mL volumetric flask, add 50 mL of water, and shake by mechanical means for 10 minutes. Dilute with water to volume, mix, and filter, discarding the first 20 mL of the filtrate. Use the subsequent filtrate as directed in the Procedure.
Procedure— Transfer 10.0 mL each of the Standard preparation, the Assay preparation, and water to serve as the blank to individual separators, each containing 10.0 mL of Buffer–dye mixture. Mix, and extract each solution with four 25-mL portions of chloroform, filtering the extracts from each solution through chloroform-moistened filter paper into separate 100-mL volumetric flasks. Dilute each solution with chloroform to volume, and mix. Concomitantly determine the absorbances of the solutions in 1-cm cells at the wavelength of maximum absorbance at about 410 nm, with a suitable spectrophotometer, using the blank to set the instrument. Calculate the quantity, in mg, of glycopyrrolate (C19H28BrNO3) in the portion of Tablets taken by the formula:
0.1C(AU / AS)
in which C is the concentration, in µg per mL, of USP Glycopyrrolate RS in the Standard preparation; and AU and AS are the absorbances of the solutions from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Elena Gonikberg, Ph.D.
Senior Scientist
(MDGRE05) Monograph Development-Gastrointestinal Renal and Endocrine
Reference Standards Lili Wang, Technical Services Scientist
711 Margareth R.C. Marques, Ph.D.
Senior Scientist
(BPC05) Biopharmaceutics05
USP32–NF27 Page 2517
Pharmacopeial Forum: Volume No. 31(4) Page 1077